OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Histaminergic neurotransmission in aging and Alzheimer's disease: A review of therapeutic opportunities and gaps
Abhijit Satpati, Thomas C. Neylan, Lea T. Grinberg
Alzheimer s & Dementia Translational Research & Clinical Interventions (2023) Vol. 9, Iss. 2
Open Access | Times Cited: 9
Abhijit Satpati, Thomas C. Neylan, Lea T. Grinberg
Alzheimer s & Dementia Translational Research & Clinical Interventions (2023) Vol. 9, Iss. 2
Open Access | Times Cited: 9
Showing 9 citing articles:
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder
Shilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 831-831
Open Access | Times Cited: 9
Shilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 831-831
Open Access | Times Cited: 9
The effect of histidine, histamine, and imidazole on electrochemical properties of Cu(II) complexes of Aβ peptides containing His-2 and His-3 motifs
Aleksandra Tobolska, Agnieszka Jabłońska, Aleksandra Suwińska, et al.
Dalton Transactions (2024) Vol. 53, Iss. 36, pp. 15359-15371
Open Access | Times Cited: 2
Aleksandra Tobolska, Agnieszka Jabłońska, Aleksandra Suwińska, et al.
Dalton Transactions (2024) Vol. 53, Iss. 36, pp. 15359-15371
Open Access | Times Cited: 2
Advances in the discovery of heterocyclic-based drugs against Alzheimer’s disease
J. Domingo Sánchez, Andrés R. Alcántara, Juan F. González, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 12, pp. 1413-1428
Closed Access | Times Cited: 6
J. Domingo Sánchez, Andrés R. Alcántara, Juan F. González, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 12, pp. 1413-1428
Closed Access | Times Cited: 6
Histaminergic System Activity in the Central Nervous System (CNS) – the Role in Neurodevelopmental and Neurodegenerative Disorders
Dariusz Szukiewicz
(2024)
Open Access | Times Cited: 1
Dariusz Szukiewicz
(2024)
Open Access | Times Cited: 1
Histaminergic System Activity in the Central Nervous System: The Role in Neurodevelopmental and Neurodegenerative Disorders
Dariusz Szukiewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9859-9859
Open Access | Times Cited: 1
Dariusz Szukiewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9859-9859
Open Access | Times Cited: 1
Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 1
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 1
Alzheimer’s Disease: An Attempt of Total Recall
Alexey P. Bolshakov, К. Б. Герасимов, Yulia V. Dobryakova
Journal of Alzheimer s Disease (2024), pp. 1-19
Closed Access
Alexey P. Bolshakov, К. Б. Герасимов, Yulia V. Dobryakova
Journal of Alzheimer s Disease (2024), pp. 1-19
Closed Access
Dihydroergotamine and Bromocriptine: Potential Drugs for the Treatment of Major Depressive Disorder and Alzheimer’s Disease Comorbidity
Mengjie Fu, Qiuchen Wang, Lihui Gao, et al.
Molecular Neurobiology (2024)
Closed Access
Mengjie Fu, Qiuchen Wang, Lihui Gao, et al.
Molecular Neurobiology (2024)
Closed Access
